{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:23:15Z","timestamp":1782476595092,"version":"3.54.5"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7284-26","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:09:11Z","timestamp":1780092551000},"source":"Crossref","is-referenced-by-count":1,"title":["Reversible Cerebral Vasoconstriction Syndrome Associated with Autoimmune Hemolytic Anemia"],"prefix":"10.2169","author":[{"given":"Itaru","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Hematology, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Onaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hirasawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11: 906-917, 2012.","DOI":"10.1016\/S1474-4422(12)70135-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Anne Ducros, Monique Boukobza, Rapha\u00ebl Porcher, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130: 3091-3101, 2007.","DOI":"10.1093\/brain\/awm256"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chen SP, Wang SJ. Pathophysiology of reversible cerebral vasoconstriction syndrome. J Biomed Sci 29: 72, 2022.","DOI":"10.1186\/s12929-022-00857-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Perillo T, Paolella C, Perrotta G, Serino A, Caranci F, Manto A. Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings. Radiol Med 127: 981-990, 2022.","DOI":"10.1007\/s11547-022-01532-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Avola G, Pezzini A. Treatment-Related Reversible Cerebral Vasoconstriction Syndrome. J Clin Med 13: 5930, 2024.","DOI":"10.3390\/jcm13195930"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chen SP, Yang AC, Fuh JL, Wang SJ. Autonomic dysfunction in reversible cerebral vasoconstriction syndromes. J Headache Pain 14: 94, 2013.","DOI":"10.1186\/1129-2377-14-94"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pilato F, Distefano M, Calandrelli R. Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Considerations. Front Neurol 11: 34, 2020.","DOI":"10.3389\/fneur.2020.00034"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Singhal AB. Reversible cerebral vasoconstriction syndrome: A review of pathogenesis, clinical presentation, and treatment. Int J Stroke 18: 1151-1160, 2023.","DOI":"10.1177\/17474930231181250"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest 127: 750-760, 2017.","DOI":"10.1172\/JCI89741"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Minneci PC, Deans KJ, Zhi H, et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 115: 3409-3417, 2005.","DOI":"10.1172\/JCI25040"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Vinchi F, Tolosano E. Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis. Oxid Med Cell Longev 2013: 396527, 2013.","DOI":"10.1155\/2013\/396527"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kothari N, Acharya S, Banode P. Reversible cerebral angiopathy after blood transfusion. Asian J Transfus Sci 6: 56-58, 2012.","DOI":"10.4103\/0973-6247.95061"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Liang H, Xu Z, Zheng Z, Lou H, Yue W. Reversible cerebral vasoconstriction syndrome following red blood cells transfusion: a case series of 7 patients. Orphanet J Rare Dis 22: 10-47, 2015.","DOI":"10.1186\/s13023-015-0268-z"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Dou YH, Fuh JL, Chen SP, Wang SJ. Reversible cerebral vasoconstriction syndrome after blood transfusion. Headache 54: 736-744, 2014.","DOI":"10.1111\/head.12319"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Verma A, Sharma G, Singh A, et al. Reversible Cerebral Vasoconstriction Syndrome Following Blood Transfusion in a Patient With Chronic Anemia: A Case Report. Clin Case Rep 12: e9618, 2024.","DOI":"10.1002\/ccr3.9618"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg 101: 1-7, 2004.","DOI":"10.3171\/jns.2004.101.1.0001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yeboah K, Bittar J, Almajali M, Soudagar Turkey M, Ramiro J. Transfusion-Related Acute Brain Injury: A Case Report on Reversible Cerebral Vasoconstriction Syndrome. Cureus 12: e9077, 2020.","DOI":"10.7759\/cureus.9077"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kazato Y, Fujii K, Oba H, et al. Reversible cerebral vasoconstriction syndrome associated with brain parenchymal hemorrhage. Brain 34: 696-699, 2012.","DOI":"10.1016\/j.braindev.2011.11.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ueki H, Sanayama Y, Miyajima A, Tsuchimochi T, Igarashi S, Sunami S. Reversible Cerebral Vasoconstriction Syndrome Promptly Diagnosed with Magnetic Resonance Imaging Including Magnetic Resonance Angiography During Immunosuppressive Therapy in a 16-Year-Old Girl with Refractory Cytopenia of Childhood. Hematol Rep 8: 6673, 2016.","DOI":"10.4081\/hr.2016.6673"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yamamoto A, Meguri Y, Fukuda A, et al. A case of reversible cerebral vasoconstriction syndrome developing during treatment of adult aplastic anemia. Ann Hematol 98: 511-513, 2019.","DOI":"10.1007\/s00277-018-3430-6"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. French KF, Hoesch RE, Allred J, et al. Repetitive use of intra-arterial verapamil in the treatment of reversible cerebral vasoconstriction syndrome. J Clin Neurosci 19: 174-176, 2012.","DOI":"10.1016\/j.jocn.2011.06.016"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Oguchi K, Fukushima K, Nakamura A, Takei YI. Reversible cerebral vasoconstriction syndrome with cardiac involvement during treatment for iron deficiency anemia: case report. BMC Neurol 21: 479, 2021.","DOI":"10.1186\/s12883-021-02509-w"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7284-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:30:46Z","timestamp":1780111846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7284-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7284-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7284-26"}}